Breakdown | |||||
TTM | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Gross Profit |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | EBIT |
-1.03M | -619.89K | 4.00M | 237.21K | -480.22K | -768.47K | EBITDA |
-1.49M | -619.88K | -613.07K | -1.42M | 399.67K | -768.47K | Net Income Common Stockholders |
-1.63M | -619.88K | -5.16M | -1.42M | 399.66K | -795.68K |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
967.59K | 5.47K | 10.69K | 469.21K | 12.27K | 84.77K | Total Assets |
8.73M | 25.00K | 56.47K | 5.06M | 5.37M | 5.50M | Total Debt |
0.00 | 0.00 | 0.00 | 60.00K | 0.00 | 489.74K | Net Debt |
-967.59K | -5.47K | -10.69K | -409.21K | -12.27K | 418.55K | Total Liabilities |
47.78K | 1.13M | 521.73K | 536.57K | 627.97K | 1.48M | Stockholders Equity |
8.68M | -1.10M | -465.25K | 4.52M | 4.72M | 3.99M |
Cash Flow | Free Cash Flow | ||||
-1.90M | -414.22K | -577.37K | -656.10K | -436.69K | -585.34K | Operating Cash Flow |
-1.91M | -414.22K | -520.76K | -575.99K | -350.48K | -470.15K | Investing Cash Flow |
2.93K | 0.00 | -56.61K | -74.50K | -40.74K | -115.19K | Financing Cash Flow |
3.43M | 409.00K | 118.85K | 1.11M | 332.30K | 520.25K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | $303.75M | 8.08 | 7.74% | ― | 29.16% | -93.72% | |
48 Neutral | $1.92B | -1.99 | -22.85% | 3.95% | 0.94% | -27.31% | |
45 Neutral | ― | -10.69% | ― | ― | ― | ||
43 Neutral | C$7.46M | ― | -29.25% | ― | ― | -16.48% | |
42 Neutral | C$29.50M | ― | -33.12% | ― | -42.96% | -110.04% | |
40 Underperform | C$6.67M | ― | -599.35% | ― | ― | 72.58% | |
37 Underperform | C$15.17M | ― | -724.49% | ― | ― | -30.65% |
Great Quest Gold Ltd. has identified 18 promising targets at the Belmont Prospect in Namibia following extensive geochemical and geophysical analysis. These findings set the stage for a drilling campaign planned for next year. Additionally, Dr. David Shaw has resigned from the company’s Board of Directors.